StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Any idea why the new warrants are priced

<< Previous

Bullboard Posts

Next >>

Comment by InvrsContrarianon Dec 05, 2020 5:01am

140 Views

Post# 32043343

RE:RE:Any idea why the new warrants are priced

Ok corrected here for the ws warrants. Each Warrant is exercisable to purchase one Common Share at any time prior to December 4, 2023 at a price of $1.10 per Common Share. There's your answer as to why the warrants are price higher. In actual fact: at wt.0.07x8=0.56+0.72=1.28 Ws. 0.18+1.10=1.28 So someone got a bargain first thing this morning when they sold for 0.16

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario